Literature DB >> 10472964

Normal aging effects for frequency doubling technology perimetry.

C W Adams1, M A Bullimore, M Wall, M Fingeret, C A Johnson.   

Abstract

PURPOSE: To determine the influence of normal aging on contrast sensitivity for frequency doubling technology (FDT) perimetry.
METHODS: Contrast sensitivity measures were obtained for frequency-doubled stimuli (0.25 cycles per degree sinusoidal gratings undergoing 25 Hz counterphase flicker) at 17 target locations (4 per quadrant plus the central 5 degrees ) using a prototype of the Welch Allyn (Skaneateles, NY)/Humphrey Systems FDT perimeter (Humphrey Systems, Dublin, CA). A total of 407 normal subjects (761 eyes) between the ages of 15 and 85 years were tested.
RESULTS: Between the ages of 15 and 60 years there was an approximately linear decrease in contrast sensitivity of 0.6 dB per decade. After the age of 70, there was a slightly greater sensitivity loss with age. There were no meaningful differences in sensitivity loss as a function of age for different visual field locations. A small but consistent reduction in contrast sensitivity (approximately 0.7 dB) was found at all visual field locations for the second eye tested that may be due to a central adaptation process.
CONCLUSIONS: Normal aging effects for FDT perimetry are similar to those obtained for conventional automated perimetry, except that the FDT perimetry aging effects do not appear to be eccentricity dependent. These normative data provide a basis for establishing a statistical analysis procedure and probability plots for FDT perimetry.

Mesh:

Year:  1999        PMID: 10472964     DOI: 10.1097/00006324-199908000-00027

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  18 in total

1.  Short wavelength automated perimetry and tamoxifen use.

Authors:  A Eisner; D F Austin; J R Samples
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

2.  Correlation between frequency doubling technology perimetry and temporal frequency characteristics in early glaucoma.

Authors:  Joseph Jy-Haw Yu; Motohiro Kiyosawa; Nobuyuki Nemoto; Keiko Momose; Hiroshi Mori; Manabu Mochizuki
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

3.  Characteristics of the normative database for the Humphrey matrix perimeter.

Authors:  Andrew John Anderson; Chris A Johnson; Murray Fingeret; John L Keltner; Paul G D Spry; Michael Wall; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

4.  Topography of the frequency doubling perimetry visual field compared with that of short wavelength and achromatic automated perimetry visual fields.

Authors:  J Landers; A Sharma; I Goldberg; S Graham
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

Review 5.  [Functional glaucoma diagnosis].

Authors:  C Erb; K Göbel
Journal:  Ophthalmologe       Date:  2009-04       Impact factor: 1.059

6.  Predicting conversion to glaucoma using standard automated perimetry and frequency doubling technology.

Authors:  Genichiro Takahashi; Shaban Demirel; Chris A Johnson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-21       Impact factor: 3.117

7.  Glaucoma detection with matrix and standard achromatic perimetry.

Authors:  Zvia Burgansky-Eliash; Gadi Wollstein; Avni Patel; Richard A Bilonick; Hiroshi Ishikawa; Larry Kagemann; William D Dilworth; Joel S Schuman
Journal:  Br J Ophthalmol       Date:  2007-01-10       Impact factor: 4.638

Review 8.  Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.

Authors:  C Gustavo De Moraes; Jeffrey M Liebmann; Leonard A Levin
Journal:  Prog Retin Eye Res       Date:  2016-10-20       Impact factor: 21.198

9.  Colour vision testing as an aid to diagnosis and management of age related maculopathy.

Authors:  G B Arden; J E Wolf
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

10.  Using frequency-doubling perimetry to detect optic neuropathy in patients with Graves' orbitopathy.

Authors:  Mário L R Monteiro; André L F Portes; Frederico C Moura; Dina B W Regensteiner
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.